| Zugriffe | |
|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 156 |
| Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 3 | 5 | 1 | 1 | 14 | 6 | 3 |
| Zugriffe | |
|---|---|
| 2021_Zirngibl_etal.pdf | 202 |
